drugset / Trial / NCT07535307
Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this clinical study is to find out how NNC0487-0111 affects, how the body uses insulin (a hormone that helps the body control blood sugar) and how well the pancreas works in people living with type 2 diabetes. There are 2 study treatments. Participants will get either NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.
Timeline
- Start
- 2026-04-10
- Primary completion
- 2027-11-11
- Completion
- 2027-12-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NNC0487-0111 | Unknown | — | Subcutaneous |